Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II Double Blind Placebo Controlled Trial of Whole Brain Radiotherapy (WBRT) and Tarceva (OSI-774, Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Multiple Brain Metastases [TACTIC]

NCT00554775 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00554775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II Double Blind Placebo Controlled Trial of Whole Brain Radiotherapy (WBRT) and Tarceva (OSI-774, Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Multiple Brain Metastases [TACTIC]
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2008
Completion date
November 30, 2010
Enrollment
80 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, metastatic cancer